David Shasha

878 total citations
27 papers, 481 citations indexed

About

David Shasha is a scholar working on Infectious Diseases, Epidemiology and Virology. According to data from OpenAlex, David Shasha has authored 27 papers receiving a total of 481 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Infectious Diseases, 9 papers in Epidemiology and 6 papers in Virology. Recurrent topics in David Shasha's work include SARS-CoV-2 and COVID-19 Research (4 papers), HIV Research and Treatment (4 papers) and CAR-T cell therapy research (3 papers). David Shasha is often cited by papers focused on SARS-CoV-2 and COVID-19 Research (4 papers), HIV Research and Treatment (4 papers) and CAR-T cell therapy research (3 papers). David Shasha collaborates with scholars based in Israel, United States and Australia. David Shasha's co-authors include Ronen Ben‐Ami, Ayelet Raz‐Pasteur, Bruce D. Walker, Mical Paul, Yael Bar‐On, Galia Zacay, Odelia Amit, Fabienne Sikron, Ofrat Beyar‐Katz and Irit Avivi and has published in prestigious journals such as SHILAP Revista de lepidopterología, Blood and Clinical Infectious Diseases.

In The Last Decade

David Shasha

26 papers receiving 475 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
David Shasha Israel 13 213 157 103 85 71 27 481
Massimiliano Secchi Italy 13 367 1.7× 185 1.2× 50 0.5× 94 1.1× 95 1.3× 20 684
Marissa B. Wilck United States 11 141 0.7× 390 2.5× 59 0.6× 123 1.4× 110 1.5× 24 560
Marc Vekemans Belgium 10 142 0.7× 77 0.5× 38 0.4× 77 0.9× 67 0.9× 20 335
F. Biron France 12 245 1.2× 168 1.1× 60 0.6× 43 0.5× 175 2.5× 42 530
Abeer Moanna United States 11 309 1.5× 208 1.3× 37 0.4× 101 1.2× 66 0.9× 20 536
Raskit Lachmann Germany 14 119 0.6× 263 1.7× 52 0.5× 159 1.9× 83 1.2× 36 646
Marie-Josée Wendling France 10 336 1.6× 249 1.6× 19 0.2× 55 0.6× 47 0.7× 22 639
Sasidharanpillai Sabeena India 12 176 0.8× 251 1.6× 65 0.6× 24 0.3× 23 0.3× 40 569
Esther Oiknine‐Djian Israel 16 331 1.6× 213 1.4× 59 0.6× 317 3.7× 20 0.3× 30 817
Cândida Abreu Portugal 14 204 1.0× 177 1.1× 95 0.9× 68 0.8× 9 0.1× 41 553

Countries citing papers authored by David Shasha

Since Specialization
Citations

This map shows the geographic impact of David Shasha's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Shasha with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Shasha more than expected).

Fields of papers citing papers by David Shasha

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Shasha. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Shasha. The network helps show where David Shasha may publish in the future.

Co-authorship network of co-authors of David Shasha

This figure shows the co-authorship network connecting the top 25 collaborators of David Shasha. A scholar is included among the top collaborators of David Shasha based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Shasha. David Shasha is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Shasha, David, et al.. (2024). High rates of Dientamoeba fragilis and Blastocystis species in children’s stool but minor clinical significance. Journal of Infection. 89(6). 106340–106340.
2.
Ram, Ron, Odelia Amit, Amos Adler, et al.. (2023). Early Antibiotic Deescalation and Discontinuation in Patients with Febrile Neutropenia after Cellular Therapy: A Single-Center Prospective Unblinded Randomized Trial. Transplantation and Cellular Therapy. 29(11). 708.e1–708.e8. 6 indexed citations
3.
Shasha, David, et al.. (2023). The clinical significance of Dientamoeba fragilis and Blastocystis in human stool—retrospective cohort study. Clinical Microbiology and Infection. 30(1). 130–136. 11 indexed citations
4.
Djajawi, Tirta M., Tricia L. Lo, Daniel S. Simpson, et al.. (2023). Candida auris uses metabolic strategies to escape and kill macrophages while avoiding robust activation of the NLRP3 inflammasome response. Cell Reports. 42(5). 112522–112522. 25 indexed citations
5.
Adler, Amos, et al.. (2022). Clinical features and outcomes of bacteremic and non-bacteremic Campylobacteriosis: a case–control study. Infection. 50(5). 1225–1231. 1 indexed citations
6.
Yakubovsky, Michal, David Shasha, Ora Halutz, et al.. (2022). Mpox Presenting as Proctitis in Men Who Have Sex With Men. Clinical Infectious Diseases. 76(3). 528–530. 32 indexed citations
7.
Ram, Ron, David Hagin, Tal Freund, et al.. (2021). Safety and Immunogenicity of the BNT162b2 mRNA COVID-19 Vaccine in Patients after Allogeneic HCT or CD19-based CART therapy—A Single-Center Prospective Cohort Study. Transplantation and Cellular Therapy. 27(9). 788–794. 94 indexed citations
8.
Ram, Ron, Odelia Amit, Amos Adler, et al.. (2021). Antibiotic Stewardship in Patients after Cellular Therapy with Febrile Neutropenia- a Single Center Prospective Unblinded Randomized Trial. Blood. 138(Supplement 1). 747–747. 2 indexed citations
9.
Shasha, David, Fabienne Sikron, Judith Tsamir, et al.. (2021). Real-world safety data for the Pfizer BNT162b2 SARS-CoV-2 vaccine: historical cohort study. Clinical Microbiology and Infection. 28(1). 130–134. 47 indexed citations
10.
Shasha, David, Liora Valinsky, Fabienne Sikron, et al.. (2019). Quadrivalent versus trivalent influenza vaccine: clinical outcomes in two influenza seasons, historical cohort study. Clinical Microbiology and Infection. 26(1). 101–106. 10 indexed citations
11.
Levy, Itzchak, Shiraz Gefen-Halevi, Israel Nissan, et al.. (2018). Delayed diagnosis of colorectal sexually transmitted diseases due to their resemblance to inflammatory bowel diseases. International Journal of Infectious Diseases. 75. 34–38. 22 indexed citations
12.
Shasha, David, et al.. (2016). Elite controller CD8+ T cells exhibit comparable viral inhibition capacity, but better sustained effector properties compared to chronic progressors. Journal of Leukocyte Biology. 100(6). 1425–1433. 21 indexed citations
13.
Raz‐Pasteur, Ayelet, David Shasha, & Mical Paul. (2015). Fluoroquinolones or macrolides alone versus combined with β-lactams for adults with community-acquired pneumonia: Systematic review and meta-analysis. International Journal of Antimicrobial Agents. 46(3). 242–248. 35 indexed citations
14.
Zigmond, Ehud, Oshrat E Tayer-Shifman, Gadi Lalazar, et al.. (2014). β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model. SHILAP Revista de lepidopterología. 11 indexed citations
15.
Shasha, David, et al.. (2014). Visceral Cat Scratch Disease with Endocarditis in an Immunocompetent Adult: A Case Report and Review of the Literature. Vector-Borne and Zoonotic Diseases. 14(3). 175–181. 7 indexed citations
16.
Yaʼacov, Ami Ben, Ehud Zigmond, Oshrat E Tayer-Shifman, et al.. (2014). β-glycosphingolipids ameliorated non-alcoholic steatohepatitis in the Psammomys obesus model. Journal of Inflammation Research. 7. 151–151. 28 indexed citations
17.
Shasha, David & Bruce D. Walker. (2013). Lessons to be Learned from Natural Control of HIV – Future Directions, Therapeutic, and Preventive Implications. Frontiers in Immunology. 4. 162–162. 18 indexed citations
18.
Elinav, Hila, et al.. (2011). HIV/AIDS among Palestinians: detection, clinical presentation, prognosis and HIV testing patterns, 1994–2010. International Journal of Infectious Diseases. 15(6). e377–e381. 2 indexed citations
19.
Elinav, Hila, et al.. (2011). HIV/AIDS profile and realities at a regional antiretroviral therapy clinic in Jerusalem: 12 years analysis. Scandinavian Journal of Infectious Diseases. 44(1). 65–69. 3 indexed citations
20.
Nir‐Paz, Ran, Colin Block, David Shasha, et al.. (2006). Macrolide, lincosamide and tetracycline susceptibility and emm characterisation of invasive Streptococcus pyogenes isolates in Israel. International Journal of Antimicrobial Agents. 28(4). 313–319. 12 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Massimiliano Secchi Breakdown of academic impact, for papers by Marissa B. Wilck Breakdown of academic impact, for papers by Marc Vekemans Breakdown of academic impact, for papers by F. Biron Breakdown of academic impact, for papers by Abeer Moanna Breakdown of academic impact, for papers by Raskit Lachmann Breakdown of academic impact, for papers by Marie-Josée Wendling Breakdown of academic impact, for papers by Sasidharanpillai Sabeena Breakdown of academic impact, for papers by Esther Oiknine‐Djian Breakdown of academic impact, for papers by Cândida Abreu
Rankless by CCL
2026